Health Care & Life Sciences » Pharmaceuticals | Biofermin Pharmaceutical Co. Ltd.

Biofermin Pharmaceutical Co. Ltd. | Cash Flow

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
3,297
3,468
2,299
2,710
3,108
3,274
Depreciation, Depletion & Amortization
1,163
1,518
1,252
1,094
928
941
Other Funds
-
-
-
-
-
1,029
Funds from Operations
3,273
3,965
2,448
3,327
3,294
3,185
Changes in Working Capital
550
1,943
1,024
292
307
669
Net Operating Cash Flow
2,724
5,907
1,423
3,618
2,987
2,517
Capital Expenditures
2,357
402
774
589
193
Sale of Fixed Assets & Businesses
-
-
36
-
-
Purchase/Sale of Investments
600
200
500
-
-
Net Investing Cash Flow
1,756
204
1,251
586
247
Cash Dividends Paid - Total
714
717
715
716
1,013
Issuance/Reduction of Debt, Net
-
-
-
-
1
Net Financing Cash Flow
717
718
716
716
1,015
Net Change in Cash
250
4,986
543
2,316
1,725
Free Cash Flow
372
5,508
649
3,130
2,824
Other Sources
1
-
-
4
-
Change in Capital Stock
3
1
1
-
-
Other Uses
-
2
13
-
55

About Biofermin Pharmaceutical Co.

View Profile
Address
Sannomiya Central Building, 12/F
Kobe Hyogo 650
Japan
Employees -
Website http://www.biofermin.co.jp
Updated 07/08/2019
Biofermin Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products, quasi-drugs, veterinary drugs, agrichemicals, cosmetics, medical equipment, foods, beverages, food additives, feeds, feed additives and other chemicals. Its products include pharmaceutical items such as New Biofermin S, Biofermin Antidiarrheal, Biofermin, Stomachic Tablets, Biofermin VC, Biofermin Laxatives, Biofermin R, etc. It also provides various clinical test services.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.